Cargando…

Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma

Detalles Bibliográficos
Autores principales: Laribi, Kamel, Baugier de Materre, Alix, Touileb, Yamina, Boursot, Charles, Sandrini, Jeremy, Cavalieri, Doriane, Pastoret, Cédric, de Leval, Laurence, Tournilhac, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812600/
https://www.ncbi.nlm.nih.gov/pubmed/35141469
http://dx.doi.org/10.1097/HS9.0000000000000675
_version_ 1784644689011408896
author Laribi, Kamel
Baugier de Materre, Alix
Touileb, Yamina
Boursot, Charles
Sandrini, Jeremy
Cavalieri, Doriane
Pastoret, Cédric
de Leval, Laurence
Tournilhac, Olivier
author_facet Laribi, Kamel
Baugier de Materre, Alix
Touileb, Yamina
Boursot, Charles
Sandrini, Jeremy
Cavalieri, Doriane
Pastoret, Cédric
de Leval, Laurence
Tournilhac, Olivier
author_sort Laribi, Kamel
collection PubMed
description
format Online
Article
Text
id pubmed-8812600
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88126002022-02-08 Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma Laribi, Kamel Baugier de Materre, Alix Touileb, Yamina Boursot, Charles Sandrini, Jeremy Cavalieri, Doriane Pastoret, Cédric de Leval, Laurence Tournilhac, Olivier Hemasphere Case Report Lippincott Williams & Wilkins 2022-02-01 /pmc/articles/PMC8812600/ /pubmed/35141469 http://dx.doi.org/10.1097/HS9.0000000000000675 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Laribi, Kamel
Baugier de Materre, Alix
Touileb, Yamina
Boursot, Charles
Sandrini, Jeremy
Cavalieri, Doriane
Pastoret, Cédric
de Leval, Laurence
Tournilhac, Olivier
Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
title Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
title_full Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
title_fullStr Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
title_full_unstemmed Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
title_short Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma
title_sort azacytidine and venetoclax in relapsed and refractory patients with angioimmunoblastic t-cell lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812600/
https://www.ncbi.nlm.nih.gov/pubmed/35141469
http://dx.doi.org/10.1097/HS9.0000000000000675
work_keys_str_mv AT laribikamel azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT baugierdematerrealix azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT touilebyamina azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT boursotcharles azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT sandrinijeremy azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT cavalieridoriane azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT pastoretcedric azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT delevallaurence azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma
AT tournilhacolivier azacytidineandvenetoclaxinrelapsedandrefractorypatientswithangioimmunoblastictcelllymphoma